Dcvc Opportunity Fund Ii, L.p. - Net Worth and Insider Trading
Dcvc Opportunity Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dcvc Opportunity Fund Ii, L.p. owns 1 companies in total, including Recursion Pharmaceuticals Inc (RXRX) .
Click here to see the complete history of Dcvc Opportunity Fund Ii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Dcvc Opportunity Fund Ii, L.p.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2021-04-15 | 10 percent owner |
Dcvc Opportunity Fund Ii, L.p. Trading Performance
Dcvc Opportunity Fund Ii, L.p. Ownership Network
Ownership Network List of Dcvc Opportunity Fund Ii, L.p.
Ownership Network Relation of Dcvc Opportunity Fund Ii, L.p.
Dcvc Opportunity Fund Ii, L.p. Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Dcvc Opportunity Fund Ii, L.p. is the 10 percent owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Christopher Gibson , Chief Financial Officer Michael Secora , and President and COO Tina Marriott Larson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Dcvc Opportunity Fund Ii, L.p. made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 346,424 shares made by Blake Borgeson , a net sale of 1,188,847 shares made by Christopher Gibson , and a net sale of 428,124 shares made by Michael Secora .
In summary, during the past 3 months, insiders sold 178,574 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 178,574 shares. During the past 18 months, 2,116,536 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,116,536 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Dcvc Opportunity Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Dcvc Opportunity Fund Ii, L.p.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Dcvc Opportunity Fund Ii, L.p.'s mailing address is: Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
